Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples